These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3066138)

  • 1. Cerebrovascular and cerebral effects of nimodipine--an update.
    Brandt L; Andersson KE; Ljunggren B; Säveland H; Ryman T
    Acta Neurochir Suppl (Wien); 1988; 45():11-20. PubMed ID: 3066138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid haemorrhage.
    Rasmussen G; Bergholdt B; Dalh B; Sunde N; Cold G; Voldby B
    Acta Neurol Scand; 1999 Mar; 99(3):182-6. PubMed ID: 10100962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage.
    Hongo K; Kobayashi S
    Neurol Res; 1993 Aug; 15(4):218-24. PubMed ID: 8105400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
    Herz RC; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
    Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
    Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
    Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
    Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.
    Sun BL; Zhang SM; Xia ZL; Yang MF; Yuan H; Zhang J; Xiu RJ
    Clin Hemorheol Microcirc; 2003; 29(3-4):337-44. PubMed ID: 14724359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium ions and calcium antagonists in ischaemia.
    Symon L; Harris RJ; Branston NM
    Acta Neurochir (Wien); 1982; 63(1-4):267-75. PubMed ID: 7102418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of nimodipine prophylaxis of cerebral vasospasm on anesthetic management during intracranial aneurysm clipping.
    Stullken EH; Johnston WE; Prough DS; Balestrieri FJ; McWhorter JM
    J Neurosurg; 1985 Feb; 62(2):200-5. PubMed ID: 3881564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of nimodipine. A review.
    Scriabine A; van den Kerckhoff W
    Ann N Y Acad Sci; 1988; 522():698-706. PubMed ID: 3288065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia.
    Harris RJ; Branston NM; Symon L; Bayhan M; Watson A
    Stroke; 1982; 13(6):759-66. PubMed ID: 6815837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the calcium antagonist nimodipine on the delayed hypoperfusion following incomplete ischemia in the rat.
    Smith ML; Kågström E; Rosén I; Siesjö BK
    J Cereb Blood Flow Metab; 1983 Dec; 3(4):543-6. PubMed ID: 6630325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nimodipine on memory impairment during spontaneous morphine withdrawal in mice: Corticosterone interaction.
    Vaseghi G; Rabbani M; Hajhashemi V
    Eur J Pharmacol; 2012 Nov; 695(1-3):83-7. PubMed ID: 22981664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW; Grolimund P; Zurbruegg HR
    Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the effect of calcium antagonists on cerebral blood flow in rats. A comparison of nimodipine and flunarizine.
    Zumkeller M; Heissler HE; Dietz H
    Neurosurg Rev; 1997; 20(4):259-68. PubMed ID: 9457721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats.
    Uematsu D; Greenberg JH; Hickey WF; Reivich M
    Stroke; 1989 Nov; 20(11):1531-7. PubMed ID: 2815188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.